| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
Kewaunee Scientific Corporation
$37.67
+0.42 (+1.13%)
Market Cap
108.06 M
EPS
3.35
P/E Ratio
11.23 $
Value Trade
35.68 K
4.61 %
Week
5.76 %
1 Month
-5.75 %
3 Month
-12.6 %
6 Month
235.32 %
5 Year
799.32 %
All Time
Cash Data
Cash Position
-
Monthly Burn
-
Runway
-
Overview
Volume
2.97 K
52 Week Range
33.27 - 59
% held by Insiders
26.1 %
% held by Institutions
41.81 %
Enterprise Value
121.52 M
Total Shares
2.87 M
Short %
2.24 %
Float Shares
2.14 M
Company Description
locked
Upcoming Catalyst
Past FDA Catalysts & PDUFA Decisions
| Date | Drug | Catalyst | Stage | Outcome | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|---|
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
Drug Pipeline Intelligence
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in KEQU
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
KEQU Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
KEQU▲ +1.1%today
Kewaunee Scientific to Report Results for First Quarter Fiscal Year 2027
Kewaunee Scientific Corporation will release its first quarter fiscal year 2027 financial results on September 9, 2026. The company, established in 1906, specializes in laboratory and healthcare furniture and operates globally with multiple manufacturing facilities. The announcement includes forward-looking statements that highlight potential risks and uncertainties affecting future performance.
Read more →KEQUKewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter
Kewaunee Scientific Corporation reported a 17.3% increase in revenue for fiscal year 2026, totaling $281.999 million. Despite this growth, net earnings fell to $9.618 million from $11.405 million the previous year. The company successfully integrated Nu Aire, improving its laboratory products portfolio, but faced challenges in the fourth quarter with a 7.5% drop in sales. Overall, Kewaunee's balance sheet improved significantly, with reduced long-term debt and a stronger equity position.
Read more →KEQUKewaunee Scientific to Report Results for Fiscal Year and Fourth Quarter
Kewaunee Scientific Corporation will release its financial results for the fourth quarter and fiscal year ending April 30, 2026, on June 23, 2026. The company, a leader in laboratory and healthcare furniture, has expanded its portfolio with the acquisition of Nu Aire. The announcement highlights the company's commitment to transparency and growth, despite potential risks associated with forward-looking statements.
Read more →KEQUKewaunee Scientific Corporation Appoints Jorge Santos as Vice President of International Sales, Laboratory Products Group
Kewaunee Scientific Corporation has appointed Jorge Santos as Vice President of International Sales for its Laboratory Products Group. This move aims to enhance the company's growth strategy, particularly in international markets such as India, the Middle East, and Asia Pacific. Santos, an industry veteran, is expected to leverage his extensive experience to support Kewaunee's global expansion efforts.
Read more →KEQUKewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2026 Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its third quarter ended January 31, 2026. Fiscal Year 2026 Third Quarter...
Kewaunee Scientific Corporation reported its third-quarter results for fiscal year 2026, showing a 3.3% increase in sales to $69.4 million. Pre-tax earnings rose significantly by 25.8%, but net earnings fell to $692,000. The company experienced a decline in domestic sales while international sales surged by 21.4%. The order backlog decreased compared to the previous year, reflecting ongoing challenges in the domestic market.
Read more →KEQUKewaunee Scientific and Nu Aire Inc. to Attend analytica 2026 in Munich Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company will attend the 2026 analytica tradeshow and conference, taking place ...
Kewaunee Scientific Corporation will attend the analytica 2026 tradeshow in Munich, showcasing its laboratory solutions alongside its subsidiary Nu Aire, Inc. The event, scheduled for March 24-27, aims to connect with over 30,000 industry professionals. The collaboration with ibs tecnomara will further enhance their offerings in laboratory infrastructure and safety solutions.
Read more →KEQUKewaunee Scientific to Report Results for Third Quarter Fiscal Year 2026
Kewaunee Scientific Corporation will announce its third quarter fiscal year 2026 financial results on March 11, 2026. The company, a leader in laboratory and healthcare furniture, has recently acquired Nu Aire, enhancing its product portfolio. The press release also includes forward-looking statements that highlight potential risks and uncertainties affecting future performance.
Read more →KEQUKewaunee Scientific to Report Results for Third Quarter Fiscal Year 2026 Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release its third quarter fiscal year 2026 financial results ...
Kewaunee Scientific Corporation plans to release its third quarter fiscal year 2026 financial results on March 11, 2026. The company, a leader in laboratory and healthcare furniture, has recently expanded its portfolio with the acquisition of Nu Aire. The announcement highlights both the company's operational continuity and the potential risks associated with its forward-looking statements.
Read more →KEQUKewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2026 Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its second quarter ended October 31, 2025. Fiscal Year 2026 Second Quarter ...
Kewaunee Scientific Corporation reported a 46.8% increase in sales for the second quarter of fiscal year 2026, reaching $70.1 million. However, net earnings decreased to $2.4 million, down from $3.0 million in the same quarter last year. The company noted strong performance in its domestic and international segments, although the corporate segment continued to face losses. The order backlog remains robust, indicating potential for future growth despite some volatility in project timelines.
Read more →KEQUKewaunee Scientific Announces Successful Debt Refinancing and Full Repayment of Seller Notes From the Company's Acquisition of Nu Aire, Inc. Kewaunee Scientific Corporation (NASDAQ: KEQU), a recognized leader in the design, manufacture, and installation of laboratory, healthcare, and...
Kewaunee Scientific Corporation announced the successful early repayment of its Seller Notes, originally due in 2027, funded through a refinancing deal with PNC Bank. This move reduces the company's debt load and interest expenses, reflecting its commitment to disciplined financial management. The company aims to leverage this flexibility for future growth initiatives.
Read more →KEQUKewaunee Scientific to Report Results for Second Quarter Fiscal Year 2026 Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release its second quarter fiscal year 2026 financial...
Kewaunee Scientific Corporation (NASDAQ: KEQU) plans to release its second quarter fiscal year 2026 financial results on December 10, 2025. The company, known for its laboratory and healthcare products, has recently acquired Nu Aire, enhancing its product offerings. The announcement includes caution regarding forward-looking statements and potential risks that may affect future performance.
Read more →KEQU▼ -21.2%on this news
Kewaunee Scientific Announces Appointment of J. Jette Campbell to Board of Directors Kewaunee Scientific Corporation (NASDAQ: KEQU), a recognized leader in the design, manufacture, and installation of laboratory, healthcare, and...
Kewaunee Scientific Corporation has appointed J. Jette Campbell to its Board of Directors, effective September 10, 2025. Campbell, a CPA with extensive experience in guiding organizations through growth, is expected to enhance Kewaunee's strategic direction. His background in the building materials and furniture sectors aligns with the company's objectives for expansion and operational improvement.
Read more →KEQUKewaunee Scientific Reports Results for First Quarter of Fiscal Year 2026 PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its first quarter ended July 31, 2025. Fiscal Year 2026 First ...
Kewaunee Scientific Corporation reported strong first-quarter results for fiscal year 2026, with sales increasing by 46.9% year-over-year. The company achieved net earnings of $3,093,000, a significant rise from the previous year's $2,193,000. Despite challenges such as project delivery volatility and a corporate segment loss, Kewaunee remains optimistic about future growth through strategic investments.
Read more →KEQUKewaunee Scientific to Attend the 2025 Arablab Live Trade Show in Dubai Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company will attend the 2025 Arablab Live tradeshow and conference, taking...
Kewaunee Scientific Corporation announced its participation in the 2025 Arablab Live tradeshow in Dubai from September 23-25. The event will feature product demonstrations and insights from Kewaunee's teams and its subsidiary NuAire. Attendees can explore innovative solutions at Kewaunee's booth, including new design tools for laboratory planning.
Read more →KEQUKEWAUNEE SCIENTIFIC CORPORATION NASDAQ: KEQU Special Note Regarding Forward-Looking Statements Certain statements in this document constitute forward-looking statements within the meaning of the Private Securities Litiga
Kewaunee Scientific Corporation (NASDAQ: KEQU) issued a special note regarding forward-looking statements as part of its Annual Report, outlining various risks and uncertainties related to its future performance. Key factors affecting the company's outlook include competitive conditions, changes in customer demands, and operational disruptions. The report highlights a notable decline in net earnings attributed to factors such as professional fees related to acquisitions and pension expenses. Although the report discusses adjusted financial measures, discrepancies between these and standard GAAP measures could lead to confusion among investors.
Read more →KEQUKewaunee Scientific to Report Results for First Quarter Fiscal Year 2026 Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release its first quarter fiscal year 2026 financial results ...
Kewaunee Scientific Corporation plans to release its first quarter fiscal year 2026 financial results on September 10, 2025. The company, known for its laboratory and healthcare products, has recently acquired Nu Aire, enhancing its product offerings. However, it acknowledges potential risks associated with this acquisition and broader economic conditions.
Read more →KEQU▲ +5.1%on this news· ran to +52% by day 3
Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its fourth quarter and its fiscal year ended April 30, 2025. Fiscal Year...
Kewaunee Scientific Corporation reported strong financial results for its fourth quarter and fiscal year ended April 30, 2025. Sales increased significantly, with a 36.1% rise in Q4 compared to the previous year. However, net earnings for the quarter decreased compared to the prior year. The company continues to integrate its recent acquisition of Nu Aire, which is expected to contribute positively to future performance.
Read more →KEQUKewaunee Scientific to Report Results for Fiscal Year and Fourth Quarter Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release financial results for its fourth quarter and fiscal...
Kewaunee Scientific Corporation plans to release its financial results for the fourth quarter and fiscal year ending April 30, 2025, on June 25, 2025. The company, known for its laboratory and healthcare products, has recently acquired Nu Aire, expanding its portfolio. However, it acknowledges various risks that could impact its future performance.
Read more →KEQUKewaunee Scientific Announces Amendment to Share Repurchase Program Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced an amendment to its existing share repurchase program. On March 12, 2025, the Board of ...
Kewaunee Scientific Corporation has amended its share repurchase program, allowing for the repurchase of an additional 100,000 shares. This decision comes after a pause in repurchases to focus on the acquisition of Nu Aire, Inc. The company remains optimistic about its capital allocation strategy and market conditions.
Read more →KEQUKewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2025 Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its third quarter ended January 31, 2025. Fiscal Year 2025 Third Quarter...
Kewaunee Scientific Corporation reported a 43.6% increase in sales for Q3 FY2025, totaling $67.2 million. However, pre-tax earnings fell by 63.7% due to costs related to the acquisition of Nu Aire. The company noted a strong order backlog of $221.6 million, indicating positive future prospects despite challenges in the international segment.
Read more →KEQUKewaunee Scientific to Report Results for Third Quarter Fiscal Year 2025 Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release its third quarter fiscal year 2025 financial results ...
Kewaunee Scientific Corporation announced plans to release its third quarter fiscal year 2025 financial results on March 12, 2025. The company, known for its laboratory and healthcare furniture products, has recently acquired Nu Aire, enhancing its product offerings. The announcement includes cautionary forward-looking statements regarding potential risks and uncertainties affecting future performance.
Read more →KEQUKewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2025 Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its second quarter ended October 31, 2024. Fiscal Year 2025 Second Quarter ...
Kewaunee Scientific Corporation reported its second quarter results for fiscal year 2025, showing a 5.3% decline in overall sales, though domestic sales rose by 6.5%. The company achieved a net earnings increase, driven by strong domestic performance, while international sales suffered due to delays in India. The order backlog reached a record high, and the recent acquisition of Nu Aire is anticipated to bolster future growth.
Read more →KEQUKewaunee Scientific to Report Results for Second Quarter Fiscal Year 2025 Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release its second quarter fiscal year 2025 financial...
Kewaunee Scientific Corporation plans to release its second quarter fiscal year 2025 financial results on December 11, 2024. The company, a leader in laboratory and healthcare furniture manufacturing, continues to navigate various risks, including economic conditions and supply chain disruptions. The upcoming financial report will provide insights into the company's performance and future prospects.
Read more →KEQU▲ +16%on this news
Kewaunee Scientific Corporation Completes Acquisition of Nu Aire Kewaunee Scientific Corporation (NASDAQ: KEQU) Kewaunee Scientific Corporation ("Kewaunee"), a leader in laboratory furniture and technical product...
Kewaunee Scientific Corporation has successfully acquired Nu Aire for $55 million, enhancing its laboratory furniture and technical product offerings. This acquisition allows Kewaunee to leverage Nu Aire's established market presence and product portfolio, particularly in biological safety cabinets and airflow products. The combined organization aims to better serve diverse industries, including healthcare and life sciences, while expanding its market reach.
Read more →KEQU▲ +16%on this news
Kewaunee Scientific Corporation Completes Acquisition of Nu Aire Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III 704/871-3274 STATESVILLE, N.C.
Kewaunee Scientific Corporation has successfully completed the acquisition of Minneapolis-based Nu Aire for $55 million. This strategic move aims to enhance Kewaunee's capabilities in laboratory furnishings and technical products, allowing the company to better serve diverse sectors including healthcare and life sciences. The acquisition also positions Kewaunee to leverage Nu Aire's existing distribution network and product offerings, ensuring a stronger market presence. Nu Aire's leadership will remain intact, with Bill Peters continuing as president, which underscores the commitment to preserving the company's legacy.
Read more →KEQUKewaunee Scientific Reports Results for First Quarter of Fiscal Year 2025 Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its first quarter ended July 31, 2024. Fiscal Year 2025 First Quarter...
Kewaunee Scientific Corporation reported a 2.9% decline in sales for Q1 FY2025, totaling $48.4 million. Pre-tax earnings also decreased significantly by 28.8% compared to the same quarter last year. Despite these challenges, the company noted a strong order backlog of $159.4 million and stable domestic demand. The decline in international sales was attributed to delays in customer construction sites in India.
Read more →KEQUKewaunee Scientific Corporation Announces Attendance at the 2024 Arablab Live Tradeshow and Conference Kewaunee Scientific Corporation (NASDAQ: KEQU), a recognized global leader in the design, manufacture, and installation of laboratory, healthcare,...
Kewaunee Scientific Corporation will attend the 2024 Arablab Live tradeshow in Dubai from September 24-26. The event will gather industry professionals from over 120 countries, allowing Kewaunee to showcase its innovative laboratory solutions and connect with global partners. The company aims to enhance its visibility and collaboration in the international market.
Read more →KEQUKewaunee Scientific to Report Results for First Quarter Fiscal Year 2025 Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release its first quarter fiscal year 2025 financial results ...
Kewaunee Scientific Corporation (NASDAQ: KEQU) will release its first quarter fiscal year 2025 financial results on September 11, 2024. The company, known for its laboratory and healthcare furniture products, has a global presence with manufacturing facilities in the U.S. and India. The announcement includes caution regarding forward-looking statements that may be affected by various risks.
Read more →KEQU▲ +8.6%on this news· ran to +23% by day 3
Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its fourth quarter and its fiscal year ended April 30, 2024. Fiscal Year...
Kewaunee Scientific Corporation reported its fiscal year 2024 results, highlighting a 5% increase in fourth-quarter sales and a significant rise in net earnings to $11,026,000. Despite a 7.2% decrease in total sales for the year, adjusted earnings showed remarkable growth. The company ended the fiscal year with a strong order backlog of $155.6 million, indicating positive market conditions. However, challenges included a decline in international sales and increased losses in the corporate segment.
Read more →KEQUKewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2024 Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its third quarter ended January 31, 2024. Fiscal Year 2024 Third Quarter...
Kewaunee Scientific Corporation reported its third-quarter results for fiscal year 2024, showing a 23.1% decrease in sales compared to the previous year. However, net earnings rose significantly to $2.521 million, up from $723,000, and EBITDA improved to $4.414 million. The company noted a strong order backlog and cash position, despite challenges in international sales.
Read more →KEQUKewaunee Scientific to Report Results for Third Quarter Fiscal Year 2024 Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release its third quarter fiscal year 2024 financial results ...
Kewaunee Scientific Corporation announced plans to release its third quarter fiscal year 2024 financial results on March 6, 2024. The company, a leader in laboratory and healthcare furniture, operates globally with manufacturing facilities in the U.S. and India. The announcement includes caution regarding forward-looking statements and potential risks affecting future performance.
Read more →KEQUKewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2024 Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its second quarter ended October 31, 2023. Fiscal Year 2024 Second Quarter ...
Kewaunee Scientific Corporation reported its second quarter results for fiscal year 2024, showing a 7.6% decrease in sales year-over-year, totaling $50.4 million. However, net earnings rose to $2.7 million, a significant improvement from a loss in the prior year. The company attributes its strong financial performance to strategic decisions made in previous quarters, particularly in its domestic operations. Despite challenges in sales, the international segment remains robust, contributing positively to the company's backlog.
Read more →KEQUKewaunee Scientific to Report Results for Second Quarter Fiscal Year 2024 Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release its second quarter fiscal year 2024 financial...
Kewaunee Scientific Corporation announced plans to release its second quarter fiscal year 2024 financial results on December 6, 2023. The company, established in 1906, specializes in laboratory and healthcare furniture products. The release will be available on their website, providing stakeholders with insights into their financial performance and future outlook.
Read more →KEQUKewaunee Scientific Corporation Announces LOOKBOOK vol. 2 and Attendance at the 2023 Arablab Live Conference Kewaunee Scientific Corporation (NASDAQ: KEQU), a recognized global leader in the design, manufacture, and installation of laboratory, healthcare,...
Kewaunee Scientific Corporation has announced the launch of its LOOKBOOK vol. 2, which will be unveiled at the 2023 Arablab Live conference in Dubai. This edition highlights recent laboratory projects and emphasizes the company's global capabilities. Kewaunee will be present at the event, inviting attendees to visit their booth for insights into their offerings.
Read more →KEQUKewaunee Scientific Reports Results for First Quarter of Fiscal Year 2024 Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its first quarter ended July 31, 2023. Fiscal Year 2024 First Quarter...
Kewaunee Scientific Corporation reported its first quarter results for fiscal year 2024, showing a slight decrease in sales but a significant improvement in net earnings and EBITDA. The company's strategic shift away from direct sales to end users has positively impacted domestic segment profitability, despite a decrease in domestic sales. International sales grew due to ongoing large projects, although overall order backlog has declined compared to prior periods.
Read more →KEQUAnnual Shareholder Meeting encouraging new discovery Worldwide
Kewaunee Scientific Corporation held its Annual Shareholder Meeting on August 23, 2023, to discuss the company's fiscal year 2023 performance and strategic direction. The results highlighted increased revenue and strong demand in the life sciences and healthcare sectors. However, the company faced challenges with raw material cost inflation that impacted profitability. Kewaunee remains focused on addressing these challenges while continuing to invest in facility upgrades and research initiatives.
Read more →KEQUCertain statements in this document constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). All statements other than statements of historica
Kewaunee Scientific Corporation NASDAQ: KEQU encouraging new discovery Worldwide Exhibit 99.1 Certain statements in this document constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). All statemen
Read more →KEQUKewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2022 Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III 704/871-3274 STATESVILLE, N.C.
Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2022 Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III 704/871-3274 STATESVILLE, N.C. December 16, 2021 PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced resu
Read more →KEQUKewaunee Scientific Reports Results for First Quarter of Fiscal Year 2022 Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III 704/871-3274 STATESVILLE, N.C.
Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2022 Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III 704/871-3274 STATESVILLE, N.C. September 8, 2021 PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for i
Read more →KEQUKewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III 704/871-3274 STATESVILLE, N.C.
Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III 704/871-3274 STATESVILLE, N.C. July 8, 2021 PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its f
Read more →KEQUKewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2021 Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III (704) 871-3274 STATESVILLE, N.C.
Reports Results for Third Quarter of Fiscal Year 2021 STATESVILLE, N.C. March 10, 2021 PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today reported results for its third quarter of fiscal year 2021, ended January 31, 2021. Sales for the quarter were $33,339,000,
Read more →KEQUKewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2021 Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III (704) 871-3274 STATESVILLE, N.C.
Reports Results for Second Quarter of Fiscal Year 2021 STATESVILLE, N.C. December 9, 2020 PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today reported results for its second quarter of fiscal year 2021, ended October 31, 2020. Sales for the quarter were $39,000,0
Read more →KEQUKewaunee Scientific Reports Results for First Quarter of Fiscal Year 2021 Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III (704) 871-3274 STATESVILLE, N.C.
Reports Results for First Quarter of Fiscal Year 2021 STATESVILLE, N.C. September 8, 2020 PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today reported results for its first quarter of fiscal year 2021, ended July 31, 2020. Sales for the quarter were $36,423,000,
Read more →KEQUSpecial Note Regarding Forward-Looking Statements Certain statements in this document constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Reform Act").
Kewaunee Scientific Corporation NASDAQ: KEQU encouraging new discovery Worldwide Exhibit 99.1 Special Note Regarding Forward-Looking Statements Certain statements in this document constitute "forward-looking" statements within the meaning of the Private Securities Litigation R
Read more →KEQUKewaunee Scientific Corporation Accelerates Growth in The Middle East & Africa Market by establishing a Local Entity in Saudi Arabia Exchange: NASDAQ (KEQU) Contact: Thomas D. Hull III 704-871-3290 Statesville, N.C.
Kewaunee Scientific Corporation Accelerates Growth in The Middle East & Africa Market by establishing a Local Entity in Saudi Arabia Statesville, N.C. July 21, 2020 Kewaunee Scientific Corporation (NASDAQ: KEQU), a recognized leader in the design, manufacture, and installation
Read more →KEQUKewaunee Scientific Announces the Appointment of a New Vice President of Manufacturing Operations Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III 704-871-3274 STATESVILLE, N.C.
Announces the Appointment of a New Vice President of Manufacturing Operations Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III 704-871-3274 STATESVILLE, N.C. June 1, 2020 /PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that Douglas
Read more →KEQUKewaunee Scientific Reports Results for Third Quarter Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III (704) 871-3274 STATESVILLE, N.C.
Kewaunee Scientific Reports Results for Third Quarter STATESVILLE, N.C. March 3, 2020 PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today reported results for its third quarter of fiscal year 2020, ended January 31, 2020. Sales for the quarter were $34,225,000, a
Read more →KEQUKewaunee Scientific Reports Results for Second Quarter, Suspension of Dividend Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III (704) 871-3274 STATESVILLE, N.C.
Kewaunee Scientific Reports Results for Second Quarter, Suspension of Dividend Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III (704) 871-3274 STATESVILLE, N.C. December 16, 2019 PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today reported resu
Read more →KEQUKewaunee Scientific Announces Release Date to Report Results for Second Quarter Fiscal Year 2020 And Quarterly Dividend Announcement STATESVILLE, N.C.
Kewaunee Scientific Announces Release Date to Report Results for Second Quarter Fiscal Year 2020 And Quarterly Dividend Announcement STATESVILLE, N.C., Nov. 26, 2019 /PRNewswire/ Kewaunee Scientific Corporation (Nasdaq: KEQU) today announced that the Company plans to release it
Read more →KEQUKewaunee Scientific Corporation NASDAQ: KEQU encouraging new discovery Worldwide 1 1 Special Note Regarding Forward-Looking Statements Certain statements in this document constitute "forward-looking" statements within th
new discovery Worldwide 1 1Exhibit 99.1 Kewaunee Scientific Corporation NASDAQ: KEQU encouraging new discovery Worldwide 1 1 Special Note Regarding Forward-Looking Statements Certain statements in this document constitute "forward-looking" statements within the meaning of the P
Read more →KEQUKewaunee Scientific Reports Results for First Quarter Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III (704) 871-3274 STATESVILLE, N.C.
Kewaunee Scientific Reports Results for First Quarter Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III (704) 871-3274 STATESVILLE, N.C. August 27, 2019 PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today reported results for its first quart
Read more →KEQUKewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter Exchange: NASDAQ (KEQU) Contact: Thomas D. Hull III 704/871-3290 STATESVILLE, N.C.
Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter Exchange: NASDAQ (KEQU) Contact: Thomas D. Hull III 704/871-3290 STATESVILLE, N.C. June 18, 2019 PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its fou
Read more →KEQUKewaunee Scientific Announces the Appointment of a New Vice President of Finance & CFO Exchange: NASDAQ (KEQU) Contact: Thomas D. Hull III 704-871-3290 STATESVILLE, N.C.
Announces the Appointment of a New Vice President of Finance & CFO Exchange: NASDAQ (KEQU) Contact: Thomas D. Hull III 704-871-3290 STATESVILLE, N.C. April 29, 2019 /PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that Donald T. Gardne
Read more →KEQUKewaunee Scientific Corporation Announces Resignation of Chief Executive and Election of New CEO Exchange: NASDAQ (KEQU) Contact: Thomas D. Hull III 704/871-3290 STATESVILLE, N.C.
Kewaunee Scientific Corporation Announces Resignation of Chief Executive and Election of New CEO Exchange: NASDAQ (KEQU) Contact: Thomas D. Hull III 704/871-3290 STATESVILLE, N.C. March 11, 2019 Kewaunee Scientific Corporation (Nasdaq: KEQU) today announced the resignati
Read more →KEQUKewaunee Scientific Declares Quarterly Dividend and Reports Results for Third Quarter Exchange: NASDAQ (KEQU) Contact: Thomas D. Hull III (704) 871-3290 STATESVILLE, N.C.
Kewaunee Scientific Declares Quarterly Dividend and Reports Results for Third Quarter Exchange: NASDAQ (KEQU) Contact: Thomas D. Hull III (704) 871-3290 STATESVILLE, N.C. February 26, 2019 PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today reported res
Read more →KEQUKewaunee Scientific Announces Appointment of Chairman of the Board Exchange: NASDAQ (KEQU) Contact: Thomas D. Hull III 704/871-3290 STATESVILLE, N.C.
Announces Appointment of Chairman of the Board STATESVILLE, N.C. February 1, 2019 Kewaunee Scientific Corporation (Nasdaq: KEQU) today announced that David S. Rhind has been appointed Chairman of the Board of Directors of the Company. Mr. Rhind succeeds William A. Shumaker who
Read more →KEQUKewaunee Scientific Reports Results for Second Quarter Exchange: NASDAQ (KEQU) Contact: Thomas D. Hull III (704) 871-3290 STATESVILLE, N.C.
Kewaunee Scientific Reports Results for Second Quarter Exchange: NASDAQ (KEQU) Contact: Thomas D. Hull III (704) 871-3290 STATESVILLE, N.C. December 4, 2018 PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today reported results for its second quarter
Read more →KEQUKewaunee Scientific Corporation NASDAQ: KEQU encouraging new discovery Worldwide Special Note Regarding Forward-Looking Statements Certain statements in this document constitute "forward-looking" statements within the me
new discovery WorldwideExhibit 99.1 Kewaunee Scientific Corporation NASDAQ: KEQU encouraging new discovery Worldwide Special Note Regarding Forward-Looking Statements Certain statements in this document constitute "forward-looking" statements within the meaning of the Private S
Read more →KEQUKewaunee Scientific Reports Results for First Quarter STATESVILLE, N.C.
Kewaunee Scientific Reports Results for First Quarter STATESVILLE, N.C., Aug. 28, 2018 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its first quarter ended July 31, 2018. Sales of $42,152,000 were recorded during the first quarter o
Read more →KEQUKewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter STATESVILLE, N.C.
Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter STATESVILLE, N.C., June 26, 2018 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its fourth quarter and its fiscal year ended April 30, 2018. Full Year, Fiscal Year
Read more →KEQUKewaunee Scientific Reports Results for Third Quarter STATESVILLE, N.C.
Kewaunee Scientific Reports Results for Third Quarter STATESVILLE, N.C., Feb. 27, 2018 /PRNewswire/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported results for its third quarter of fiscal year 2018, ended January 31, 2018. Third Quarter Fiscal Year 2018 Results
Read more →KEQUKewaunee Scientific Reports Results for Second Quarter STATESVILLE, N.C.
Kewaunee Scientific Reports Results for Second Quarter STATESVILLE, N.C., Dec. 5, 2017 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today reported results for its second quarter of fiscal year 2018, ended October 31, 2017. Net earnings for the quarter increase
Read more →KEQUKewaunee Scientific Reports Results for Fourth Quarter and Fiscal Year STATESVILLE, N.C.
Kewaunee Scientific Reports Results for Fourth Quarter and Fiscal Year STATESVILLE, N.C., June 20, 2017 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its fourth quarter and its fiscal year ended April 30, 2017. Fourth Quarter 2017 Re
Read more →KEQUKewaunee Scientific Awarded $18.5 Million Contract in Kuwait Exchange: NASDAQ (KEQU) Contact: Thomas D. Hull III 704-871-3290 STATESVILLE, North Carolina, USA
Kewaunee Scientific Awarded $18.5 Million Contract in Kuwait Exchange: NASDAQ (KEQU) STATESVILLE, North Carolina, USA, September 19, 2016 / PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that, through its dealer ATC, it has been awarded a contract
Read more →KEQUKewaunee Scientific Announces the Appointment of a New Vice President of Manufacturing Operations Exchange: NASDAQ (KEQU) Contact: David M. Rausch 704-871-3274 STATESVILLE, N.C.
Announces the Appointment of a New Vice President of Manufacturing Operations Exchange: NASDAQ (KEQU) Contact: David M. Rausch 704-871-3274 STATESVILLE, N.C. May 2, 2016 /PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that Michael G. Rok
Read more →KEQUKewaunee Scientific Announces the Appointment of a New Vice President of Finance & CFO Exchange: NASDAQ (KEQU) Contact: David M. Rausch 704-871-3274 STATESVILLE, N.C.
Announces the Appointment of a New Vice President of Finance & CFO Exchange: NASDAQ (KEQU) Contact: David M. Rausch 704-871-3274 STATESVILLE, N.C. November 2, 2015 /PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that Thomas D. Hull II
Read more →KEQUKewaunee Scientific Announces CFO Retirement Exchange: NASDAQ (KEQU) Contact: D. Michael Parker 704/871-3290 STATESVILLE
Announces CFO Retirement Exchange: NASDAQ (KEQU) Contact: D. Michael Parker 704/871-3290 STATESVILLE, NORTH CAROLINA, July 16, 2015 / PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) reported today that D. Michael Parker, its Senior Vice President, Chie
Read more →KEQUKewaunee Scientific Reports Results for Year and Fourth Quarter STATESVILLE, N.C.
Kewaunee Scientific Reports Results for Year and Fourth Quarter STATESVILLE, N.C., June 23, 2015 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its year and fourth quarter ended April 30, 2015. Fiscal Year 2015 Results Sales for the
Read more →KEQUKeith M. Gehl Elected to Kewaunee Scientific Board of Directors Exchange: NASDAQ (KEQU) Contact: D. Michael Parker 704-871-3290 STATESVILLE, NC
Elected to Kewaunee Scientific Board of Directors STATESVILLE, NC, May 5, 2015 /PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) announced today the election of Keith M. Gehl to Kewaunee Scientific s Board of Directors, effective April 29, 2015. Mr. Gehl is a residen
Read more →KEQUKewaunee Scientific Corporation Announces China Expansion Plans Exchange: NASDAQ (KEQU) Contact: D. Michael Parker 704-871-3290 STATESVILLE
Kewaunee Scientific Corporation Announces China Expansion Plans Exchange: NASDAQ (KEQU) Contact: D. Michael Parker 704-871-3290 STATESVILLE, NORTH CAROLINA, USA, May 22, 2014 / PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU), a recognized global leader in the d
Read more →KEQUKewaunee Scientific Reports Record Sales and Earnings for First Quarter STATESVILLE, N.C.
Kewaunee Scientific Reports Record Sales and Earnings for First Quarter STATESVILLE, N.C., Aug. 27, 2013 /PRNewswire/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported record sales and earnings for its first quarter ended July 31, 2013. Net earnings for the quart
Read more →KEQUKewaunee Scientific Announces Buyout of its International Operations Minority Shares Exchange: NASDAQ (KEQU) Contact: D. Michael Parker 704-871-3290 STATESVILLE, NC
Announces Buyout of its International Operations Minority Shares STATESVILLE, NC, July 8, 2013 / PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU), a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furnit
Read more →KEQUKewaunee Scientific Reports Record Sales for Year and Fourth Quarter STATESVILLE, N.C.
Kewaunee Scientific Reports Record Sales for Year and Fourth Quarter STATESVILLE, N.C., June 25, 2013 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its fourth quarter and year ended April 30, 2013. Fiscal Year 2013 Results Sales for
Read more →KEQUDONALD F. SHAW ELECTED TO KEWAUNEE SCIENTIFIC BOARD OF DIRECTORS Exchange: NASDAQ (KEQU) Contact: D. Michael Parker 704-871-3290 STATESVILLE, NC
KEWAUNEE SCIENTIFIC BOARD OF DIRECTORS Exchange: NASDAQ (KEQU) Contact: D. Michael Parker 704-871-3290 STATESVILLE, NC, June 3, 2013 / PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) announced today the election of Donald F. Shaw to Kewaunee Scientific s Boar
Read more →KEQUKewaunee Scientific Announces CEO Retirement and Appointment of Successor Exchange: NASDAQ (KEQU) Contact: D. Michael Parker 704/871-3290 STATESVILLE, N.C.
Announces CEO Retirement and Appointment of Successor Exchange: NASDAQ (KEQU) Contact: D. Michael Parker 704/871-3290 STATESVILLE, N.C. April 29, 2013 Kewaunee Scientific Corporation (Nasdaq: KEQU) today announced that William A. Shumaker, Kewaunee s Chairman of
Read more →KEQUKewaunee Scientific Reports Improved Results for Third Quarter STATESVILLE, N.C.
Kewaunee Scientific Reports Improved Results for Third Quarter STATESVILLE, N.C., Feb. 26, 2013 /PRNewswire/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported sales and earnings for its third quarter ended January 31, 2013. Sales for the quarter were $27,450,000,
Read more →KEQUKewaunee Scientific Reports Record Sales for Second Quarter STATESVILLE, N.C.
Kewaunee Scientific Reports Record Sales for Second Quarter STATESVILLE, N.C., Nov. 27, 2012 /PRNewswire/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported sales and earnings for its second quarter ended October 31, 2012. Sales for the quarter were a record $31,1
Read more →KEQUKewaunee Scientific Reports Improved Sales and Earnings for First Quarter STATESVILLE, N.C.
Kewaunee Scientific Reports Improved Sales and Earnings for First Quarter STATESVILLE, N.C., Aug. 21, 2012 /PRNewswire/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported sales and earnings for its first quarter ended July 31, 2012. Net earnings for the quarter we
Read more →KEQUKewaunee Scientific Reports Significantly Improved Results for Fourth Quarter STATESVILLE, N.C.
Kewaunee Scientific Reports Significantly Improved Results for Fourth Quarter STATESVILLE, N.C., June 26, 2012 /PRNewswire/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today announced results for its fourth quarter and year ended April 30, 2012. Fourth Quarter Results Ne
Read more →KEQUKewaunee Scientific Announces Promotion of David M. Rausch Exchange: NASDAQ (KEQU) Contact: D. M. Parker 704-871-3290 STATESVILLE, NC
Kewaunee Scientific Announces Promotion of David M. Rausch Exchange: NASDAQ (KEQU) Contact: D. M. Parker 704-871-3290 STATESVILLE, NC, March 13, 2012/PRNewsire/ Kewaunee Scientific Corporation (Nasdaq: KEQU) today announced that at a meeting of its Board
Read more →KEQUKewaunee Scientific Announces Results for Third Quarter STATESVILLE, N.C.
Kewaunee Scientific Announces Results for Third Quarter STATESVILLE, N.C., Feb. 28, 2012 /PRNewswire/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today announced the financial results for its third quarter ended January 31, 2012. Sales for the quarter were $21,574,000, do
Read more →KEQUKewaunee Scientific Announces Results for Second Quarter STATESVILLE, N.C.
Kewaunee Scientific Announces Results for Second Quarter STATESVILLE, N.C., Nov. 30, 2011 /PRNewswire/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today announced the financial results for its second quarter ended October 31, 2011. Sales for the quarter were $25,962,000,
Read more →KEQUKewaunee Scientific Reports Sales and Earnings For First Quarter STATESVILLE, N.C.
Kewaunee Scientific Reports Sales and Earnings For First Quarter STATESVILLE, N.C., Aug. 24, 2011 /PRNewswire/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported sales and earnings for its first quarter ended July 31, 2011. Sales for the quarter were $26,321,000,
Read more →KEQUKewaunee Scientific Reports Sales and Earnings for First Quarter STATESVILLE, N.C., Aug. 24 /PRNewswire-FirstCall/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported sales and earnings for its first quarter
Kewaunee Scientific Reports Sales and Earnings for First Quarter STATESVILLE, N.C., Aug. 24 /PRNewswire-FirstCall/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported sales and earnings for its first quarter ended July 31, 2010. Sales for the quarter were $24,858,0
Read more →KEQUUnassociated Document Kewaunee Scientific Reports Results for Year and Fourth Quarter STATESVILLE, N.C., June 23 /PRNewswire-FirstCall/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today announced results for its ye
Scientific Reports Results for Year and Fourth Quarter N.C., June 23 /PRNewswire-FirstCall/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today announced results for its year and fourth quarter ended April 30, the year were $99,093,000, down 4.7% from sales of $103,978,000
Read more →KEQURoss W. McCanless Elected to Kewaunee Scientific Board of Directors Exchange: NASDAQ (KEQU) Contact: D. Michael Parker 704/871-3290 STATESVILLE, NC
Kewaunee Scientific Board of Directors Exchange: NASDAQ (KEQU) Contact: D. Michael Parker 704/871-3290 STATESVILLE, NC, April 22, 2010 Kewaunee Scientific Corporation (NASDAQ: KEQU) announced today the election of Ross W. (Bill) McCanless to Kewaunee Scientific s Boar
Read more →KEQUUnassociated Document Kewaunee Scientific Announces Results for Third Quarter and Quarterly Dividend Exchange: NASDAQ (KEQU) Contact: D. Michael Parker 704/871-3290 STATESVILLE, NC
Scientific Announces for Third Quarter and Quarterly Dividend Exchange: NASDAQ (KEQU) Contact: D. Michael Parker 704/871-3290 NC, February 25, 2010--Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its third quarter ended January 31, 2010. the qu
Read more →KEQUUnassociated Document Kewaunee Scientific Reports Increased Sales and Earnings For First Quarter Exchange: NASDAQ (KEQU) Contact: D. Michael Parker 704/871-3290 STATESVILLE, N.C.
Exchange: NASDAQ (KEQU) Contact: D. Michael Parker 704/871-3290 N.C. August 25, 2009 - Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported increased sales and earnings for its first quarter ended July 31, earnings for the quarter increased 9% to $1,071,000, or $0
Read more →KEQUUnassociated Document Kewaunee Scientific Reports Record Results Net Earnings for Year Increase 36%, Sales Increase 16% Exchange: NASDAQ (KEQU) Contact: D. Michael Parker 704/871-3290 STATESVILLE, N.C.
Scientific Reports Record Results Earnings for Year Increase 36%, Exchange: NASDAQ (KEQU) Contact: D. Michael Parker 704/871-3290 N.C. June 24, 2009 -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported record sales, earnings, and order backlog for its fiscal ye
Read more →KEQUPatrick L. McCrory Elected to Kewaunee Scientific Board of Directors Exchange: NASDAQ (KEQU) Contact: Beth Phillips 704/871-3201 STATESVILLE, NC
Patrick L. McCrory Elected to Kewaunee Scientific Board of Directors Exchange: NASDAQ (KEQU) Contact: Beth Phillips 704/871-3201 STATESVILLE, NC, May 27, 2009 Kewaunee Scientific Corporation (NASDAQ: KEQU) announced today the election of Patrick L. McCrory to Kewaune
Read more →KEQUUnassociated Document Kewaunee Scientific Announces Higher Third Quarter Sales and Earnings and Quarterly Dividend Exchange: NASDAQ (KEQU) Contact: D. Michael Parker 704/871-3290 STATESVILLE, NC
Scientific Announces Third Quarter Sales and Earnings Exchange: NASDAQ (KEQU) Contact: D. Michael Parker 704/871-3290 NC, February 26, 2009-Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its third quarter ended January 31, 2009. earnings for the
Read more →KEQUUnassociated Document Kewaunee Scientific Announces Record Sales and Earnings for Second Quarter Exchange: NASDAQ (KEQU) Contact: D. Michael Parker 704/871-3290 STATESVILLE, N.C.
Scientific Announces Sales and Earnings for Second Quarter Exchange: NASDAQ (KEQU) Contact: D. Michael Parker 704/871-3290 N.C., December 3, 2008 /PRNewswire-/ - Kewaunee Scientific Corporation (Nasdaq: announced record sales and earnings for its second quarter ended Octob
Read more →KEQUv124793_ex99-1.txt Kewaunee Scientific Announces Improved First Quarter Results Exchange: NASDAQ (KEQU) Contact: D. Michael Parker 704/871-3290 STATESVILLE, N.C.
Kewaunee Scientific Announces Improved First Quarter Results Exchange: NASDAQ (KEQU) Contact: D. Michael Parker STATESVILLE, N.C. August 26, 2008 -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today announced results for its first quarter ended July 31, 2008. Net earnings
Read more →KEQUv118083_ex99-1.txt KEWAUNEE SCIENTIFIC REPORTS RESULTS NET EARNINGS FOR YEAR INCREASE 104%, SALES INCREASE 9.9% Exchange: NASDAQ (KEQU) Contact: D. Michael Parker 704/871-3290 STATESVILLE, N.C.
KEWAUNEE SCIENTIFIC REPORTS RESULTS NET EARNINGS FOR YEAR INCREASE 104%, Exchange: NASDAQ (KEQU) Contact: D. Michael Parker STATESVILLE, N.C. June 24, 2008 Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported results for its fiscal year and fourth quarter ended April
Read more →KEQUv105058_ex99-1.txt Kewaunee Scientific Reports Third Quarter Results Net Earnings Increase 150%, Revenues Increase 21% Quarterly Dividend Declared Exchange: NASDAQ (KEQU) Contact: D. Michael Parker 704/871-3290 STATESVIL
Kewaunee Scientific Reports Third Quarter Results Net Earnings Increase 150%, Revenues Increase 21% Quarterly Dividend Declared Exchange: NASDAQ (KEQU) Contact: D. Michael Parker STATESVILLE, NC, February 27, 2008--Kewaunee Scientific Corporation (NASDAQ: KEQU) today reporte
Read more →KEQUv085742_ex99-1.txt Kewaunee Scientific Announces First Quarter Results and Quarterly Dividend Exchange: NASDAQ (KEQU) Contact: D. Michael Parker 704/871-3290 STATESVILLE, N.C.
Kewaunee Scientific Announces First Quarter Results and Quarterly Dividend Exchange: NASDAQ (KEQU) Contact: D. Michael Parker STATESVILLE, N.C. August 22, 2007 -- Kewaunee Scientific Corporation (Nasdaq: KEQU - news) today announced results for its first quarter ended July 3
Read more →KEQUv079267_ex99-1.txt Kewaunee Scientific Reports Results For Year and Fourth Quarter Exchange: NASDAQ (KEQU) STATESVILLE, N.C.
Kewaunee Scientific Reports Results For Year and Fourth Quarter Exchange: NASDAQ (KEQU) STATESVILLE, N.C. June 26, 2007 -- Kewaunee Scientific Corporation (Nasdaq: KEQU - news) today reported results for its fiscal year and fourth quarter ended Net earnings for the year were
Read more →KEQUKEWAUNEE SCIENTIFIC ANNOUNCES THIRD QUARTER RESULTS AND QUARTERLY DIVIDEND STATESVILLE, N.C., Feb. 28 /PRNewswire-FirstCall/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported results for its third quarter
KEWAUNEE SCIENTIFIC ANNOUNCES THIRD QUARTER RESULTS AND QUARTERLY DIVIDEND STATESVILLE, N.C., Feb. 28 /PRNewswire-FirstCall/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported results for its third quarter ended Net earnings for the quarter were $321,000, or $0.1
Read more →KEQUKEWAUNEE SCIENTIFIC REPORTS RESULTS FOR THE SECOND QUARTER AND QUARTERLY DIVIDEND STATESVILLE, N.C., Nov. 29 /PRNewswire-FirstCall/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported results for its second
KEWAUNEE SCIENTIFIC REPORTS RESULTS FOR THE SECOND QUARTER AND QUARTERLY STATESVILLE, N.C., Nov. 29 /PRNewswire-FirstCall/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported results for its second quarter ended Net earnings for the quarter were $569,000, or $0.23
Read more →KEQUKEWAUNEE SCIENTIFIC REPORTS RESULTS FOR FIRST QUARTER AND QUARTERLY DIVIDEND STATESVILLE, N.C., Aug. 23 /PRNewswire-FirstCall/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported results for its first quarte
KEWAUNEE SCIENTIFIC REPORTS RESULTS FOR FIRST QUARTER AND QUARTERLY DIVIDEND STATESVILLE, N.C., Aug. 23 /PRNewswire-FirstCall/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported results for its first quarter ended Sales for the quarter were $19,294,000, a decreas
Read more →KEQUKEWAUNEE SCIENTIFIC REPORTS RESULTS FOR YEAR AND FOURTH QUARTER STATESVILLE, N.C., June 21 /PRNewswire-FirstCall/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported results for its fiscal year and fourth qu
KEWAUNEE SCIENTIFIC REPORTS RESULTS FOR YEAR AND FOURTH QUARTER STATESVILLE, N.C., June 21 /PRNewswire-FirstCall/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported results for its fiscal year and fourth quarter ended April 30, 2006. Sales for the year were $84,
Read more →KEQUKEWAUNEE SCIENTIFIC ANNOUNCES THIRD QUARTER RESULTS AND QUARTERLY DIVIDEND STATESVILLE, N.C., Feb. 22 /PRNewswire-FirstCall/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported results for its third quarter
KEWAUNEE SCIENTIFIC ANNOUNCES THIRD QUARTER RESULTS AND QUARTERLY DIVIDEND STATESVILLE, N.C., Feb. 22 /PRNewswire-FirstCall/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported results for its third quarter ended Sales for the quarter were $17,724,000, an increase
Read more →KEQUKEWAUNEE SCIENTIFIC REPORTS RESULTS FOR SECOND QUARTER STATESVILLE, N.C., Nov. 22 /PRNewswire-FirstCall/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported results for its second quarter ended
KEWAUNEE SCIENTIFIC REPORTS RESULTS FOR SECOND QUARTER STATESVILLE, N.C., Nov. 22 /PRNewswire-FirstCall/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported results for its second quarter ended October 31, 2005. Sales for the quarter were $22,319,000, an increase
Read more →KEQUKEWAUNEE SCIENTIFIC REPORTS RESULTS FOR FIRST QUARTER STATESVILLE, N.C., Aug. 24 /PRNewswire-FirstCall/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported results for its first quarter ended
KEWAUNEE SCIENTIFIC REPORTS RESULTS FOR FIRST QUARTER STATESVILLE, N.C., Aug. 24 /PRNewswire-FirstCall/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported results for its first quarter ended Net earnings for the quarter were $763,000, or $0.31 per diluted share.
Read more →KEQUKEWAUNEE SCIENTIFIC REPORTS RESULTS FOR YEAR AND FOURTH QUARTER STATESVILLE, N.C., June 15 /PRNewswire-FirstCall/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported results for its fiscal year and fourth qu
KEWAUNEE SCIENTIFIC REPORTS RESULTS FOR YEAR AND FOURTH QUARTER STATESVILLE, N.C., June 15 /PRNewswire-FirstCall/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported results for its fiscal year and fourth quarter ended April 30, 2005. Sales for the year were $73,4
Read more →KEQUKEWAUNEE SCIENTIFIC CORPORATION ANNOUNCES SALE OF TEXAS FACILITY STATESVILLE, N.C., May 18 /PRNewswire-FirstCall/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported the sale of its building and land in Lock
KEWAUNEE SCIENTIFIC CORPORATION ANNOUNCES SALE OF TEXAS FACILITY STATESVILLE, N.C., May 18 /PRNewswire-FirstCall/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported the sale of its building and land in Lockhart, Texas to a non-affiliated third party for $2,500,00
Read more →KEQUKewaunee Scientific Announces Second Quarter Results STATESVILLE, N.C., Nov. 22 /PRNewswire-FirstCall/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported results for its second quarter ended
Kewaunee Scientific Announces Second Quarter Results STATESVILLE, N.C., Nov. 22 /PRNewswire-FirstCall/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported results for its second quarter ended October 31, 2004. Sales for the quarter were $18,365,000, a decline of 2
Read more →KEQUKewaunee Scientific Reports Results for First Quarter STATESVILLE, N.C., Aug. 25 /PRNewswire-FirstCall/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported results for its first quarter ended
Kewaunee Scientific Reports Results for First Quarter STATESVILLE, N.C., Aug. 25 /PRNewswire-FirstCall/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported results for its first quarter ended Sales for the quarter were $20,288,000, as compared to sales of $24,213
Read more →Competitive Position
How KEQU ranks across every disease it competes inCompetitive Position is a premium feature
See how KEQU ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial